FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to compositions, kits, method of preventing and treating cancer using tumour-associated recombinant MVA (modified vaccinia Ankara) viruses coding the antigens: PSA (prostate specific antigen) and PAP (prostatic acid phosphatase). The given recombinant MVA viruses are able to induce B- and T-cell responses. The recombinant MVA viruses may be also used in a combination with taxane.
EFFECT: recombinant modified viruses are effective in preventing and treating cancer.
23 cl, 27 dwg, 6 ex
| Title |
Year |
Author |
Number |
| COMBINATION THERAPY FOR TREATING CANCER WITH POXVIRUS EXPRESSING TUMOUR ANTIGEN AND ANTAGONIST AND/OR AGONIST OF IMMUNE CHECKPOINT INHIBITOR |
2014 |
- Rauntri, Rajan
- Foj, Syuzan
- Mendl, Stefani
- Delker, Alen
|
RU2714142C2 |
| THERAPY FOR TREATING CANCER BY INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION OF RECOMBINANT MVA CODING 4-1BBL (CD137L) AND/OR CD40L |
2019 |
- Lauterbach, Henning
- Hinterberger, Maria
- Medina Echeverz, Jose
|
RU2830601C2 |
| COMBINATION THERAPY FOR CANCER TREATMENT USING RECOMBINANT MVA AND ANTIBODIES INTRODUCED INTRAVENOUSLY |
2018 |
- Hochrein, Hubertus
- Lauterbach, Henning
- Medina Echeverz, Jose
- Habjan, Matthias
|
RU2795103C2 |
| PERSONALIZED VACCINE |
2018 |
- Benzhama, Kaidr
- Silvestr, Natali
- Marshan, Zhan-Batist
- Grelle, Benua
|
RU2779987C2 |
| COMBINED THERAPY FOR TREATING CANCER USING A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST OR AGONIST OF AN IMMUNE CONTROL POINT MOLECULE |
2015 |
- Foy Susan
- Mandl Stefanie
- Rountree Ryan
- Franzusoff Alex
|
RU2724433C2 |
| RECOMBINANT GENE STRUCTURE FOR INDUCING IMMUNE RESPONSE, RECOMBINANT POLYPEPTIDE AND VACCINE |
2005 |
- Chzhan Shuzhen'
- Lin' Chen
- Sun' Vehn'Sin'
- Tsin' Khan'Tszjun'
- Chzhou Chun'Sja
- Ljan Sjao
- Van Dunmehj
- Ma Vehn'Bo
- Chzhan Sjuejan'
- Fu Min
|
RU2396348C2 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPEUTIC REGIMENS BASED ON VACCINES |
2013 |
- Binder, Joseph John
- Cho, Helen Kim
- Dermyer, Michael Robert
- Jooss, Karin Ute
|
RU2737765C2 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPY SCHEMES BASED ON VACCINES |
2013 |
- Binder Dzhozef Dzhon
- Chou Khelen Kim
- Dermier Majkl Robert
- Joss Karin Yute
- Pies Brajen Gregori
- Ten Dzhojs Tsi
- Tsaj Van To
|
RU2609651C2 |
| ANNEXIN A3 MONOCLONAL ANTIBODIES FOR DETECTION OF PROSTATE CARCINOMA |
2007 |
|
RU2467335C2 |
| METHODS OF TREATING CANCER USING ANTAGONISTS BINDING TO COMPONENTS OF THE SIGNAL PATH PD-1, AND TAXANES |
2014 |
|
RU2719487C2 |
